147 related articles for article (PubMed ID: 37852322)
1. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication.
Luganini A; Sibille G; Pavan M; Mello Grand M; Sainas S; Boschi D; Lolli ML; Chiorino G; Gribaudo G
Antiviral Res; 2023 Nov; 219():105734. PubMed ID: 37852322
[TBL] [Abstract][Full Text] [Related]
2. The Novel
Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
[TBL] [Abstract][Full Text] [Related]
3. The New Generation
Calistri A; Luganini A; Mognetti B; Elder E; Sibille G; Conciatori V; Del Vecchio C; Sainas S; Boschi D; Montserrat N; Mirazimi A; Lolli ML; Gribaudo G; Parolin C
Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442810
[TBL] [Abstract][Full Text] [Related]
4. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
[TBL] [Abstract][Full Text] [Related]
6. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
[TBL] [Abstract][Full Text] [Related]
7. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
McCutcheon KM; Jordan R; Mawhorter ME; Noton SL; Powers JG; Fearns R; Cihlar T; Perron M
J Virol; 2016 Feb; 90(4):1705-17. PubMed ID: 26608311
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells.
Corsello T; Qu Y; Ivanciuc T; Garofalo RP; Casola A
Front Immunol; 2022; 13():886701. PubMed ID: 36032066
[TBL] [Abstract][Full Text] [Related]
9. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
[TBL] [Abstract][Full Text] [Related]
10. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
[TBL] [Abstract][Full Text] [Related]
11. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
[TBL] [Abstract][Full Text] [Related]
13. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
[TBL] [Abstract][Full Text] [Related]
14. Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
Zhang W; Zhang L; Zan Y; Du N; Yang Y; Tien P
J Gen Virol; 2015 Jan; 96(Pt 1):170-182. PubMed ID: 25228491
[TBL] [Abstract][Full Text] [Related]
15. Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
Busse DC; Habgood-Coote D; Clare S; Brandt C; Bassano I; Kaforou M; Herberg J; Levin M; Eléouët JF; Kellam P; Tregoning JS
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611756
[TBL] [Abstract][Full Text] [Related]
16. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
[TBL] [Abstract][Full Text] [Related]
18. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide exerts anti-respiratory syncytial virus activity by up-regulating heme oxygenase-1 independent of interferon responses in human airway epithelial cells.
Che S; Zhou N; Liu Y; Xie J; Liu E
Mol Biol Rep; 2023 May; 50(5):4261-4272. PubMed ID: 36918433
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus: prospects for new and emerging therapeutics.
Jorquera PA; Tripp RA
Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
